106 related articles for article (PubMed ID: 25675044)
21. Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers: results after 12 years since International FIGO 2000 Consensus.
Braga A; Uberti EM; Fajardo Mdo C; Viggiano M; Sun SY; Grillo BM; Padilha SL; de Andrade JM; de Souza CB; Madi JM; Maestá I; Silveira E
J Reprod Med; 2014; 59(5-6):241-7. PubMed ID: 24937964
[TBL] [Abstract][Full Text] [Related]
22. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
23. [Utility of hCG dosage in the management of gestational trophoblastic diseases].
Zohoun AG; Hounmenou K; Mechtani Sel I; Razine R; Dami A; Filali A; Rahali DM; Tellal S
Ann Biol Clin (Paris); 2013; 71(6):639-43. PubMed ID: 24342784
[TBL] [Abstract][Full Text] [Related]
24. Complete molar pregnancy in adolescents from North and South America: Clinical presentation and risk of gestational trophoblastic neoplasia.
Soares RR; Maestá I; Colón J; Braga A; Salazar A; Charry RC; Sun SY; Goldstein DP; Berkowitz RS
Gynecol Oncol; 2016 Sep; 142(3):496-500. PubMed ID: 27423380
[TBL] [Abstract][Full Text] [Related]
25. Influence of age as a factor in the outcome of gestational trophoblastic neoplasia.
Palmer JE; Hancock BW; Tidy JA
J Reprod Med; 2008 Aug; 53(8):565-74. PubMed ID: 18773619
[TBL] [Abstract][Full Text] [Related]
26. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
[TBL] [Abstract][Full Text] [Related]
27. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
[TBL] [Abstract][Full Text] [Related]
28. Advances in the clinical laboratory detection of gestational trophoblastic disease.
Seki K; Matsui H; Sekiya S
Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
[TBL] [Abstract][Full Text] [Related]
29. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
30. 15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage.
Brown J; Naumann RW; Seckl MJ; Schink J
Gynecol Oncol; 2017 Jan; 144(1):200-207. PubMed ID: 27743739
[TBL] [Abstract][Full Text] [Related]
31. [CroDiab NET--electronic diabetes registry].
Poljicanin T; Pavlić-Renar I; Metelko Z
Acta Med Croatica; 2005; 59(3):185-9. PubMed ID: 16095190
[TBL] [Abstract][Full Text] [Related]
32. Gestational trophoblastic neoplasia in adolescents.
Rauh-Hain JA; Growdon WB; Braga A; Goldstein DP; Berkowitz RS
J Reprod Med; 2012; 57(5-6):237-42. PubMed ID: 22696819
[TBL] [Abstract][Full Text] [Related]
33. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
Dantas PRS; Maestá I; Filho JR; Junior JA; Elias KM; Howoritz N; Braga A; Berkowitz RS
Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
[TBL] [Abstract][Full Text] [Related]
34. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
[TBL] [Abstract][Full Text] [Related]
35. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
Cole LA; Muller CY
Gynecol Oncol; 2010 Jan; 116(1):3-9. PubMed ID: 19822356
[TBL] [Abstract][Full Text] [Related]
36. Current management of gestational trophoblastic neoplasia.
Goldstein DP; Berkowitz RS
Hematol Oncol Clin North Am; 2012 Feb; 26(1):111-31. PubMed ID: 22244665
[TBL] [Abstract][Full Text] [Related]
37. [Malignant trophoblastic tumors (MTT) treated in the years 1955-2004 in trophoblastic disease center in the Czech Republic (TDC-CZ): clinical-pathological features, curability, typing, pathogenesis].
Zavadil M; Feyereisl J; Safár P; Pán M
Ceska Gynekol; 2004 Dec; 69 Suppl 1():9-15. PubMed ID: 15748020
[TBL] [Abstract][Full Text] [Related]
38. The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia.
Clark LH; Staley SA; Barber EL; Wysham WZ; Kim KH; Soper JT
Am J Obstet Gynecol; 2016 Aug; 215(2):217.e1-5. PubMed ID: 26875944
[TBL] [Abstract][Full Text] [Related]
39. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
40. A specific database for providing local and national level of integration of clinical data in cystic fibrosis.
Leal T; Reychler G; Mailleux P; Gigi J; Godding V; Lebecque P
J Cyst Fibros; 2007 May; 6(3):187-93. PubMed ID: 17027346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
